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Abstracts / Urological Science 26 (2015) S50eS81S76diseases. We aimed to use the National Health Insurance Research Data-
base (NHIRD) to investigate the relationship of urolithiasis and acute
myocardial infarction (AMI).
Materials and Methods: Patients with the diagnosis of urolithiasis (ICD-9-
CM codes 592.0, 592.1, 592.9) before Jan 1, 2003 were retrieved from the
NHIRD's Longitudinal Health Insurance Database 2005 as the case group.
Patients without urolithiasis werematched with 1:4 ratio regarding to sex,
age and comorbidities as control group. Both groups were followed till
myocardial infarction were encountered (ICD-9-CM codes 410, 411, 412,
413, 414, or 440) or till the end of 2012.
Results: Total 37,052 cases and 148,209 controls were inducted into this
study. The risk of AMI was higher among patients with urolithiasis
(adjusted hazard ratio [aHR] 1.07, 95% conﬁdence interval [CI] 1.03e1.13).
We detected a signiﬁcant association between urinary calculi and intu-
bation (aHR 1.53, 95% CI 1.36e1.73), intensive care unit treatment (aHR
1.22, 95% CI 1.13e1.32), heart failure (aHR 1.59, 95% CI 1.42e1.78), shock
(aHR 1.53, 95% CI 1.32e1.77) and arrhythmias (aHR 1.18, 95% CI 1.06e1.33).
Patients with kidney stones have the highest risk of AMI.
Conclusion: Urolithisis is associated with higher risks of AMI and several
complications of AMI. Treating urolithiasis more aggressively is recom-
mended for patients with comorbidities related to AMI.Laparoscopy
NDP100:
IMPACT OF POSITIVE SURGICAL MARGIN ON PROSTATE CANCER
RECURRENCE AFTER ROBOT-ASSISTED LAPAROSCOPIC RADICAL
PROSTATECTOMY
Sheng-Tang Wu, Chien-Chang Kao, Chu-Wei Tsao, Shou-Hung Tang, En
Meng, Guang-Huan Sun, Dah-Shyong Yu, Pao-Luo Fan, Hong-I.
Chen, Sun-Yran Chang, Tai-Lung Cha. Division of Urology, Department of
Surgery, Tri-Service General Hospital, National Defense Medical Center,
Taipei, Taiwan
Purpose: We analyzed the impact of positive surgical margins on prostate
speciﬁc antigen (PSA) recurrence in patients after robot-assisted laparo-
scopic radical prostatectomy (RARP) as deﬁnitive local treatment for
prostate cancer
Materials and Methods: There were 294 consecutive patients who un-
derwent RARP for prostate cancer between Jan 2008 and Aug 2013. Pa-
tients without undetectable PSA within 3 months after RARP, or with
postoperative adjuvant radiotherapy due to adverse pathological features
that suggested by NCCN guideline were excluded. We retrospectively
analyzed the records of 219 patients. Demographic features, initial and
followed PSA, Gleason score, and pathologic stage of prostate were
reviewed.
Results: A total of 20 patients (9.1%) developed biochemical recurrence.
Forty-one patients (18.7%) with positive surgical margins (PSM+). In all
patients (n¼ 219), with biochemical recurrence (BCR+, n¼ 20), and no BCR
(BCR-, n¼ 199) patients group, the mean agewas 64.6, 61.9, and 64.9 years
in each group; the mean follow tine was 39.1 (12-80), 48.2 (16-79), and
36.8 (12-80) months after RARP; mean pre-RARP PSA was 13.1, 19.2, and
12.4 ng/mL. In the BCR+ group, 15.0% cases with PSM+. In the BCR- group,
the PSM+ cases were 19.1%. In the 41 patients with PSM+, there were 3
(9.1%) with BCR+ during the follow-up. In the 178 patients whowere PSM-,
17 (9.5%) cases developed BCR+. The mean BCR time after RARP was 9.4 (4-
28) months.
Conclusion: Our limited data indicate that surgical margin status is not an
independent predictor of PSA recurrence in patients who underwent RARP
as deﬁnitive local therapy for prostate cancer.
NDP101:
COMPARE BALLOON DILATATION WITH DIRECT ZERO DEGREE
TELESCOPE DISSECTION OF RETROPERITONEAL SPACE FOR
UNROOFING OF RENAL CYST IN TAIPEI CITY HOSPITAL EXPERIENCE
Jehow cheng 1,2, Yu-Wei Lai 1,2, Thomas Y. Hsueh 1,2, Andy C. Huang 1,2, Yi-
Chun Chiu 1,2, Shiou-Sheng Chen 1,2, Allen W. Chiu 1,2. 1Divisions of Urology,
Department of Surgery, Taipei City Hospital, Taiwan; 2National Yang-Ming
University, School of Medicine, TaiwanPurpose: To Compare the results of balloon dilatation with direct zero
degree telescope dissection of retroperitoneal space for unrooﬁng of renal
cyst
Materials and methods: Total sixteen patient had undergone retro-
peritoneoscopic cyst unrooﬁng at our hospital during January 2010 to
December 2014 were collected and analyzed. Sixteen patients
with symptomatic simple renal cysts had undergone unrooﬁng of the
cyst with balloon dilatation (BD) in nine cases and direct zero degree
telescope dissection (DZDTD) in eight others. Three trocars (10 mm,
10 mm and 5 mm) were inserted in all the procedure. A 2 cm ﬂank
muscle-split incision was made and retroperitoneoscopy was per-
formed through the same incision in all the procedure. Then, the cyst
was unroofed
Results: The mean operative time was 64.4 minutes in the DZDTD group
and 85.6 minutes in the BA group. The In the DZDTD group, the mean
postoperative staywas 4 days, and the time to feedingwas 9.4 hours. In the
BD group, the mean postoperative stay was 4.6 days, and the time to
feeding was 37.4 hours.
Estimated blood loss in the DZDTD group was 56mL. Estimated blood
loss in the BD group was 46mL. No case required conversion to open
surgery. No signiﬁcant intraoperative complication was noted. Only
No patient need blood transfusion. The postoperative complication rate
was 0%. Most complications were minor and did not need speciﬁc
treatment.
Conclusion: DZDTD and BD techniques for unrooﬁng of renal cysts
are safe, effective and minimally invasive. DZDTD is easy to perform
and seem to be a more time-saving procedure when compared to BD.
DZDTD seem be feasible and effective to treat symptomatic simple renal
cysts.Andrology
NDP102:
THE EXPERIENCE OF IMPLEMENTING SMOKING CESSATION TO
IMPROVE SEXUAL HEALTH IN MEN
Wei-Che Weng 1, Hui-Cheng Tseng 2. 1Department of Urology, Kaohsiung
Municipal United Hospital, Taiwan; 2College of Nursing, Kaohsiung Medical
University, Taiwan
Purpose: Erectile dysfunction is considered a signiﬁcant public health
problem and is estimated to affect over 180million men in theworld. Large
cross-sectional and longitudinal epidemiological studies indicated that
chronic smokers are about 1.5 t 2-times as likely as nonsmokers to report
erectile dysfunction after controlling for age and confounding cardiovas-
cular risk factors. Although stopping smoking enhances many aspects of
health, the positive health beneﬁts of smoking cessation are not sufﬁcient
enough for many smokers to considered quitting. The aim of this studywas
to examine whether smoking cessation was associated with sexual health
improvements, with the hope that the results could inﬂuence men to stop
smoking.
Materials and Methods: The male smokers, irrespective of erectile
dysfunction status, who were motivated to stop smoking, were enrolled
in a 12-week smoking cessation program using a nicotine transdermal
patch treatment and adjunctive counseling. The participants were
accessed at smoking regularly, at mid-treatment and at a 4-week post
cessation follow-up. Circumferential change and subjective sexual arousal
indices, as well as self-report sexual functioning were assessed at each
visit.
Results: There were total 65 smoking men involved in our study and
completed the follow-up. There were 20 successful quitters and 45
relapsed men. The quitted showed enhanced erectile tumescence re-
sponses, and faster onset to reach maximum subjective sexual arousal
compared with the relapse men.
Conclusion: Smoking cessation signiﬁcantly enhances both physiological
and self-reported indices on sexual health in long term male smoker,
irrespective of baseline erectile impairment. We hoped that this result may
serve as a novel means to motivate men to stop smoking. The cigarette
smoking brings about the cardiovascular ﬂow change and it is the main
cause of erectile dysfunction. Smoking cessation was found to improve
both physiological and self-reported indices on sexual health in long term
